Vertex Pharmaceuticals IncorporatedVRTXNASDAQ

|||

Overview News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Alerts

Want to monitor VRTX?

Get notified when price crosses targets, volume spikes, or RSI hits oversold

Create free account to monitor VRTX

Key Statistics

About

Vertex Pharmaceuticals is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry.

Sector

Professional, Scientific, and Technical Services

Industry

Research and Development in Biotechnology (except Nanobiotechnology)

CEO

Reshma Kewalramani

vrtx.com/ →

News

Should CoreWeave Investors Worry About Michael Intrator's Latest Move?

fool.com

Is Vital Farms Stock a Buy or Sell After the Founder Sold 25,000 Shares?

fool.com

Want to Buy Artificial Intelligence (AI) Stocks in 2026? These 2 Companies Could Net You Millions in Retirement.

fool.com

This Dirt Cheap $7 Stock Could Make You Filthy Rich

fool.com

BBNX Investors Have Opportunity to Join Beta Bionics, Inc. Fraud Investigation with the Schall Law Firm

businesswire.com

ARDT Investors Have Opportunity to Lead Ardent Health, Inc. Securities Fraud Lawsuit with the Schall Law Firm

businesswire.com

Dividend ETFs: HDV Offers Higher Yield Than VIG

fool.com

Where Will Nike Be in 5 Years?

fool.com

Is Rigetti Computing Stock a Buy or Sell After a Director Dumped Shares Worth $1.3 Million?

fool.com

Trump seeks to stop courts, creditors from seizing Venezuelan oil revenue in the U.S.

cnbc.com

GQRE vs. REET: The Rising ETF Against the Largest Global Real Estate ETF

fool.com

SOXX Delivered Larger Gains Than XLK, but With Greater Risk and Volatility

fool.com

President Sells 25,000 EverCommerce Shares for $250,000

fool.com

Why Ubiquiti Rallied 67% in 2025

fool.com

From Just-in-Time To Just-in-Case, Legendary Executive Warns Of A Minerals Reckoning

feeds.benzinga.com

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance

Alerts

Key Statistics

About

News

Should CoreWeave Investors Worry About Michael Intrator's Latest Move?

Is Vital Farms Stock a Buy or Sell After the Founder Sold 25,000 Shares?

Want to Buy Artificial Intelligence (AI) Stocks in 2026? These 2 Companies Could Net You Millions in Retirement.

This Dirt Cheap $7 Stock Could Make You Filthy Rich

BBNX Investors Have Opportunity to Join Beta Bionics, Inc. Fraud Investigation with the Schall Law Firm

Is Nvidia Stock a Buy for 2026?

Assessing Qualcomm Stock Amid Its AI Ambitions

Director Sells 25,000 JFrog Shares for $1.8 Million

Top Cannabis Stocks in the U.S. Heading Into January 2026

NuScale Power Is Interesting, but Here's What I'd Buy Instead

ARDT Investors Have Opportunity to Lead Ardent Health, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Dividend ETFs: HDV Offers Higher Yield Than VIG

Where Will Nike Be in 5 Years?

Is Rigetti Computing Stock a Buy or Sell After a Director Dumped Shares Worth $1.3 Million?

Trump seeks to stop courts, creditors from seizing Venezuelan oil revenue in the U.S.

GQRE vs. REET: The Rising ETF Against the Largest Global Real Estate ETF

SOXX Delivered Larger Gains Than XLK, but With Greater Risk and Volatility

President Sells 25,000 EverCommerce Shares for $250,000

Why Ubiquiti Rallied 67% in 2025

From Just-in-Time To Just-in-Case, Legendary Executive Warns Of A Minerals Reckoning

Explore More

Should CoreWeave Investors Worry About Michael Intrator's Latest Move?

Is Vital Farms Stock a Buy or Sell After the Founder Sold 25,000 Shares?

Want to Buy Artificial Intelligence (AI) Stocks in 2026? These 2 Companies Could Net You Millions in Retirement.

This Dirt Cheap $7 Stock Could Make You Filthy Rich

BBNX Investors Have Opportunity to Join Beta Bionics, Inc. Fraud Investigation with the Schall Law Firm

Is Nvidia Stock a Buy for 2026?

Assessing Qualcomm Stock Amid Its AI Ambitions

Director Sells 25,000 JFrog Shares for $1.8 Million

Top Cannabis Stocks in the U.S. Heading Into January 2026

NuScale Power Is Interesting, but Here's What I'd Buy Instead

ARDT Investors Have Opportunity to Lead Ardent Health, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Dividend ETFs: HDV Offers Higher Yield Than VIG

Where Will Nike Be in 5 Years?

Is Rigetti Computing Stock a Buy or Sell After a Director Dumped Shares Worth $1.3 Million?

Trump seeks to stop courts, creditors from seizing Venezuelan oil revenue in the U.S.

GQRE vs. REET: The Rising ETF Against the Largest Global Real Estate ETF

SOXX Delivered Larger Gains Than XLK, but With Greater Risk and Volatility

President Sells 25,000 EverCommerce Shares for $250,000

Why Ubiquiti Rallied 67% in 2025

From Just-in-Time To Just-in-Case, Legendary Executive Warns Of A Minerals Reckoning